Nonalcoholic fatty pancreas disease: An emerging clinical challenge
Authors:
- Cheng-Lei ZhangCZCheng-Lei Zhang
- Jing-Jiao WangJWJing-Jiao Wang
- Jian-Ning LiJLJian-Ning Li
- Yi YangYYYi Yang
Open Access
- 16 August 2021
- journal article
- review article
- Published by Baishideng Publishing Group Inc. in World Journal of Clinical Cases
- Vol. 9 (23) , 6624-6638
Abstract
Nonalcoholic fatty pancreas disease (NAFPD) is an emerging disease that has gained an increasing amount of attention in recent years. It describes fat accumulation in the pancreas with insignificant alcohol consumption, but the pathogenesis is largely unknown. A wide range of terms have been used to describe the phenomenon of pancreatic fat accumulation, but NAFPD remains an under-recognized and non-independent disorder. Obesity, age, sex, race, and unhealthy lifestyle are established independent risk factors for NAFPD, which is strongly associated with metabolic syndrome, type 2 diabetes, pancreatitis, pancreatic fistula, pancreatic cancer, and nonalcoholic fatty liver disease. At present, imaging techniques are common diagnostic aids, but uniform criteria and consensus are lacking. Therapeutically, healthy diet, weight loss, and exercise are the mainstays to reduce pancreatic fat accumulation. It can be seen that there is a limited understanding of NAFPD at this stage and further exploration is needed. Previous studies have revealed that NAFPD may directly affect diagnosis and clinical decision-making. Therefore, exploring the pathophysiological mechanism and clinical associations of NAFPD is a major challenge for researchers and clinicians.Keywords
This publication has 152 references indexed in Scilit:
- The Association between Nonalcoholic Fatty Pancreas Disease and DiabetesPLOS ONE, 2013
- Association between non-alcoholic fatty pancreatic disease (nafpd) and the metabolic syndrome: case–control retrospective studyCardiovascular Diabetology, 2013
- Preoperative computed tomography measurements of pancreatic steatosis and visceral fat: prognostic markers for dissemination and lethality of pancreatic adenocarcinomaHPB, 2011
- Estimation of Hepatic Proton-Density Fat Fraction by Using MR Imaging at 3.0 TRadiology, 2011
- Comparison of Fat–Water MRI and Single‐voxel MRS in the Assessment of Hepatic and Pancreatic Fat Fractions in HumansObesity, 2010
- Multiecho water‐fat separation and simultaneous R estimation with multifrequency fat spectrum modelingMagnetic Resonance in Medicine, 2008
- Pancreas volumes in humans from birth to age one hundred taking into account sex, obesity, and presence of type‐2 diabetesClinical Anatomy, 2007
- Nonalcoholic fatty pancreas diseaseHPB, 2007
- Hepato-pancreato-biliary fat: the good, the bad and the uglyHPB, 2007
- Mechanisms linking obesity to insulin resistance and type 2 diabetesNature, 2006